Your browser doesn't support javascript.
loading
Chemotherapy-Induced Oral Complications and Prophylaxis Strategies.
Sledzinska, Aleksandra; Sledzinska, Paulina; Bebyn, Marek; Komisarek, Oskar.
Afiliación
  • Sledzinska A; Faculty of Medicine, Poznan University of Medical Sciences, Poznan, Poland.
  • Sledzinska P; Molecular Oncology and Genetics Department, Innovative Medical Forum, The F. Lukaszczyk Oncology Center, Bydgoszcz, Poland.
  • Bebyn M; Molecular Oncology and Genetics Department, Innovative Medical Forum, The F. Lukaszczyk Oncology Center, Bydgoszcz, Poland.
  • Komisarek O; Department of Maxillofacial Orthopedics and Orthodontics, Poznan University of Medical Sciences, Poznan, Poland.
Cancer Invest ; 41(5): 432-455, 2023 May.
Article en En | MEDLINE | ID: mdl-36892292
ABSTRACT
Cancer is currently a significant therapeutic challenge and is frequently connected with numerous adverse effects. Despite many improvements in chemotherapy, oral complications are common, leading to poor quality of life and chemotherapeutic dose reduction, which impair survival. This review summarizes the most common dental complications in patients receiving chemotherapy. We mainly focus on oral mucositis as it is a major cause of dose-limiting toxicity. Furthermore, oral candidiasis, viral infections, and xerostomia will be discussed.

Conclusions:

preventing complications is significantly more important than treating them. All patients beginning systemic anticancer treatment should undergo a thorough oral examination and get appropriate prophylaxis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estomatitis / Candidiasis Bucal / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Cancer Invest Año: 2023 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estomatitis / Candidiasis Bucal / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Cancer Invest Año: 2023 Tipo del documento: Article País de afiliación: Polonia